Understanding the Treatment Preferences of Neuroendocrine Tumor Patients Using Discrete Choice Experiments

Matthew Anaka; David Lok Hang Chan; Sharon  Pattison; Alia Thawer; Bryan  Franco; Lesley Moody; Christopher Jackson; Eva Segelov; Simron Singh

Understanding the Treatment Preferences of Neuroendocrine Tumor Patients Using Discrete Choice Experiments

Matthew Anaka, David Lok Hang Chan, Sharon Pattison, Alia Thawer, Bryan Franco, Lesley Moody, Christopher Jackson, Eva Segelov, Simron Singh

Medicine Monash Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	462
Number of pages	1
Journal	Pancreas
Volume	49
Issue number	3
Publication status	Published - Mar 2020
Event	Symposium of the North American Neuroendocrine Tumor Society - Boston, United States of America Duration: 3 Oct 2019 → 5 Oct 2019

Cite this

@article{885ddd24eb6444e6939d57acd125ac33,

title = "Understanding the Treatment Preferences of Neuroendocrine Tumor Patients Using Discrete Choice Experiments",

author = "Matthew Anaka and Chan, \{David Lok Hang\} and Sharon Pattison and Alia Thawer and Bryan Franco and Lesley Moody and Christopher Jackson and Eva Segelov and Simron Singh",

year = "2020",

month = mar,

language = "English",

volume = "49",

pages = "462",

journal = "Pancreas",

issn = "0885-3177",

publisher = "Lippincott Williams \& Wilkins",

number = "3",

note = "Symposium of the North American Neuroendocrine Tumor Society ; Conference date: 03-10-2019 Through 05-10-2019",

}

TY - JOUR

T1 - Understanding the Treatment Preferences of Neuroendocrine Tumor Patients Using Discrete Choice Experiments

AU - Anaka, Matthew

AU - Chan, David Lok Hang

AU - Pattison, Sharon

AU - Thawer, Alia

AU - Franco, Bryan

AU - Moody, Lesley

AU - Jackson, Christopher

AU - Segelov, Eva

AU - Singh, Simron

PY - 2020/3

Y1 - 2020/3

M3 - Meeting Abstract

SN - 0885-3177

VL - 49

SP - 462

JO - Pancreas

JF - Pancreas

IS - 3

T2 - Symposium of the North American Neuroendocrine Tumor Society

Y2 - 3 October 2019 through 5 October 2019

ER -